“ Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration ”, Braz. J. Pharm. Sci., vol. 50, no. 1, pp. 63–72, Mar. 2014, doi: 10.1590/S1984-82502011000100006.